Albert M. Maguire, MD

Ophthalmology
Accepting new patients
Sees patients age 18 and up
Scheie Eye Institute Perelman
View 2 additional locations
Make an appointmentCall 215-662-8100
Penn Medicine Provider

About me

  • Emeritus Professor CE of Ophthalmology

My education and training

  • Medical School: Harvard Medical School
  • Residency: Yale-New Haven Hospital
  • Residency: Johns Hopkins Hospital
  • Fellowship: Beaumont Hospital, Royal Oak

Spoken languages

English
English

Reviews

Average Rating

1265 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
June 2025
a very, very pleasant person, doctor a joy to have as one doctor
Anonymous
June 2025
very skilled and knowledgeable
Anonymous
June 2025
pro
Anonymous
June 2025
i had an infection in my eye and they cured it my eyes actually improved at my age that is great

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Maguire is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Pierce, EA, Aleman, TS, Jayasundera, KT, Ashimaley, BS, Kim, E, Rashid, A, Jaskolka, MC, Myers, RL, Lam, BL, Bailey, ST, Comander, JI, Lauer, AK, Maguire, AM and Pennesi, ME Gene Editing for CEP290-Associated Retinal Degeneration , New England Journal of Medicine: 2024,Published online May 6, 2024

Tsui, JC, Huang, V, Kolmeyer, AM, Miller, CG, Mishkin, A and Maguire, AM Efficacy of maribavir in valganciclovir-resistant cytomegalovirus retinitis , Retina Cases Brief Rep, 18(2): 2024,164-167

Tsui JC, Wong, MB, Kim, BJ, Maguire, AM, Scoles, D, VanderBeek, BL, Brucker, AJ Appropriateness of ophthalmic symptoms triage by a popular online artificial intelligence chatbot , Eye (Lond), 37(17): 2023,692-3693

Ashtari, M, Cook, P, Lipin, M, Yu, Y, Ying, G-S, Maguire, AM, Bennett, J, Gee, J, Zhang, H Dynamic structural remodeling of the human visual system prompted by bilateral retinal gene therapy , Current Research in Neurobiology, 4: 2023,online 4 June 2023

Bennett, J and Maguire, AM Lessons Learned from the Development of the First FDA-Approved Gene Therapy Drug, Voretigene Neparvovec-rzyl; , Cold Spring Harb Perspect Med , 13: 2023,a041307

Tsui, JC, Wong, MB, Kim, BJ, Maguire, AM, Scoles, D, VanderBeek, BL, Brucker, AJ Appropriateness of ophthalmic symptoms triage by a popular online artifician intelligence chatbot , Eye (Lond), 32(e24): 2023

Andersen T, Miller CG, Xia T, Pulido JS, Brucker AJ, Maguire AM Vitreoretinal lymphoma presenting as frosted branch angiitis in a patient with diffuse large B-cell lymphoma. , Am J Ophthalmol Case Rep, 30: 2023,101838

Andersen, T, Miller, CG, Xia, T, Pulido, JS, Brucker, AJ, Maguire, AM Vitreoretinal lymphoma presenting as frosted branch angiitis in a patient with diffuse large B-cell lymphoma , Am J Ophthalmol Case Rep, 30: 2023,101838

Silson, EH, Baker, CI, Aleman, TS, Maguire, AM, Bennett, J and Ashtari, M Motion-selective areas V5/MT and MST appear resistant to deterioration in choroideremia , Neuroimage Clin, 38: 2023,103384

Bennett, J, Aleman, EMM, Maguire, HK, Weber, ML, Maguire, WM, Maja, A, O'Neil, EC, Maguire, AM, Miller, AJ and Aleman, TS Optimization and validation of a virtual reality orientation and ombility test for inherited retinal degenerations , Transl Vis Sci Technol, 12(1): 2023,28